October 31, 2023

Condensate-targeted drug discovery powered by phenotypic signatures

Poster presented at the Society of Biomolecular Imaging and Informatics (SBI2) 10th Annual Conference

> Download the PDF file

Media Contact

Investor Contact

Scott Peterson, Ph.D.
SVP, Corporate Development and Investor Relations
Dewpoint Therapeutics
Dewpoint Therapeutics
451 D Street, Suite 104
Boston, MA 02210
© 2019-2023 - Dewpoint Therapeutics

Design: SALIENCE Communication / Publiepress
Scientific animation: Visual Science